|
|
Line 459: |
Line 459: |
| |- | | |- |
| ! colspan="4" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Surface Lesions of Oral Mucosa | | ! colspan="4" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Surface Lesions of Oral Mucosa |
| !
| |
| !
| |
| ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization |
| ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features |
Line 467: |
Line 465: |
| ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | |
| |- | | |- |
| | colspan="3" rowspan="16" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | rowspan="16" style="background: #DCDCDC; padding: 5px; text-align: left;" | |
| * White | | * White |
| | rowspan="11" |Epithelial | | | rowspan="11" | |
| |Geographic tongue | | * Epithelial |
| | | |
| | * Geographic tongue |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" | | | | style="background: #F5F5F5; padding: 5px;" | |
Line 478: |
Line 478: |
| | style="background: #F5F5F5; padding: 5px;" | | | | style="background: #F5F5F5; padding: 5px;" | |
| |- | | |- |
| |Hairy tongue | | | |
| | * Hairy tongue |
| | | | | |
| | | | | |
Line 486: |
Line 487: |
| | | | | |
| |- | | |- |
| |Leukoedema | | | |
| | * Leukoedema |
| | | | | |
| | | | | |
Line 494: |
Line 496: |
| | | | | |
| |- | | |- |
| |White sponge nevus | | | |
| | * White sponge nevus |
| | | | | |
| | | | | |
Line 502: |
Line 505: |
| | | | | |
| |- | | |- |
| |Hairy leukoplakia | | | |
| | * Hairy leukoplakia |
| | | | | |
| | | | | |
Line 510: |
Line 514: |
| | | | | |
| |- | | |- |
| |Lichen planus | | | |
| | * Lichen planus |
| | | | | |
| | | | | |
Line 518: |
Line 523: |
| | | | | |
| |- | | |- |
| |Nicotinic stomatitis | | | |
| | * Nicotinic stomatitis |
| | | | | |
| | | | | |
Line 526: |
Line 532: |
| | | | | |
| |- | | |- |
| |Hyperkeratosis | | | |
| | * Hyperkeratosis |
| | | | | |
| | | | | |
Line 534: |
Line 541: |
| | | | | |
| |- | | |- |
| |Epithelial dysplasia | | | |
| | * Epithelial dysplasia |
| | | | | |
| | | | | |
Line 542: |
Line 550: |
| | | | | |
| |- | | |- |
| |Carcinoma in-situ | | | |
| | * Carcinoma in-situ |
| | | | | |
| | | | | |
Line 550: |
Line 559: |
| | | | | |
| |- | | |- |
| |Squamous cell carcinoma | | | |
| | * Squamous cell carcinoma |
| | | | | |
| | | | | |
Line 558: |
Line 568: |
| | | | | |
| |- | | |- |
| | rowspan="2" |Surface debris | | | rowspan="2" | |
| |Candidiosis | | * Surface debris |
| | | |
| | * Candidiosis |
| | | | | |
| | | | | |
Line 567: |
Line 579: |
| | | | | |
| |- | | |- |
| |Burn | | | |
| | * Burn |
| | | | | |
| | | | | |
Line 575: |
Line 588: |
| | | | | |
| |- | | |- |
| | rowspan="3" |Subepithelial | | | rowspan="3" | |
| |Congenital keratotic cyst | | * Subepithelial |
| | | |
| | * Congenital keratotic cyst |
| | | | | |
| | | | | |
Line 584: |
Line 599: |
| | | | | |
| |- | | |- |
| |Scar | | | |
| | * Scar |
| | | | | |
| | | | | |
Line 592: |
Line 608: |
| | | | | |
| |- | | |- |
| |Fordyce granules | | | |
| | * Fordyce granules |
| | | | | |
| | | | | |
Line 600: |
Line 617: |
| | | | | |
| |- | | |- |
| | colspan="3" rowspan="20" | | | | rowspan="20" | |
| * Pigmented | | * Pigmented |
| | rowspan="11" |Localized | | | rowspan="11" | |
| | rowspan="3" |Intravascular | | * Localized |
| |Hemangioma | | | rowspan="3" | |
| | * Intravascular |
| | | |
| | * Hemangioma |
| | | | | |
| | | | | |
Line 611: |
Line 631: |
| | | | | |
| |- | | |- |
| |Varix | | | |
| | * Varix |
| | | | | |
| | | | | |
Line 618: |
Line 639: |
| | | | | |
| |- | | |- |
| |Kaposi sarcoma | | | |
| | * Kaposi sarcoma |
| | | | | |
| | | | | |
Line 625: |
Line 647: |
| | | | | |
| |- | | |- |
| | rowspan="3" |Extravasated blood | | | rowspan="3" | |
| |Hematoma | | * Extravasated blood |
| | | |
| | * Hematoma |
| | | | | |
| | | | | |
Line 633: |
Line 657: |
| | | | | |
| |- | | |- |
| |Ecchymosis | | | |
| | * Ecchymosis |
| | | | | |
| | | | | |
Line 640: |
Line 665: |
| | | | | |
| |- | | |- |
| |Petechiae | | | |
| | * Petechiae |
| | | | | |
| | | | | |
Line 647: |
Line 673: |
| | | | | |
| |- | | |- |
| | rowspan="4" |Melanocytic | | | rowspan="4" | |
| |Oral melanocytic macule | | * Melanocytic |
| | | |
| | * Oral melanocytic macule |
| | | | | |
| | | | | |
Line 655: |
Line 683: |
| | | | | |
| |- | | |- |
| |Nevus | | | |
| | * Nevus |
| | | | | |
| | | | | |
Line 662: |
Line 691: |
| | | | | |
| |- | | |- |
| |Melanoma | | | |
| | * Melanoma |
| | | | | |
| | | | | |
Line 669: |
Line 699: |
| | | | | |
| |- | | |- |
| |Ephelis | | | |
| | * Ephelis |
| | | | | |
| | | | | |
Line 676: |
Line 707: |
| | | | | |
| |- | | |- |
| |Tattoo | | | |
| | * Tattoo |
| | | | | |
| | | | | |
Line 684: |
Line 716: |
| | | | | |
| |- | | |- |
| | rowspan="9" |Diffuse | | | rowspan="9" | |
| |Hereditary | | * Diffuse |
| | | |
| | * Hereditary |
| | | | | |
| | | | | |
Line 693: |
Line 727: |
| | | | | |
| |- | | |- |
| |Addison's disease | | | |
| | * Addison's disease |
| | | | | |
| | | | | |
Line 701: |
Line 736: |
| | | | | |
| |- | | |- |
| |Heavy metal ingestion | | | |
| | * Heavy metal ingestion |
| | | | | |
| | | | | |
Line 709: |
Line 745: |
| | | | | |
| |- | | |- |
| |Peutz-Jeghers syndrome | | | |
| | * Peutz-Jeghers syndrome |
| | | | | |
| | | | | |
Line 717: |
Line 754: |
| | | | | |
| |- | | |- |
| |Neurofibromatosis | | | |
| | * Neurofibromatosis |
| | | | | |
| | | | | |
Line 725: |
Line 763: |
| | | | | |
| |- | | |- |
| |Polyostotic fibrous dysplasia | | | |
| | * Polyostotic fibrous dysplasia |
| | | | | |
| | | | | |
Line 733: |
Line 772: |
| | | | | |
| |- | | |- |
| |Pregnancy | | | |
| | * Pregnancy |
| | | | | |
| | | | | |
Line 741: |
Line 781: |
| | | | | |
| |- | | |- |
| |Medication | | | |
| | * Medication |
| | | | | |
| | | | | |
Line 749: |
Line 790: |
| | | | | |
| |- | | |- |
| |Smoker's melanosis | | | |
| | * Smoker's melanosis |
| | | | | |
| | | | | |
Line 757: |
Line 799: |
| | | | | |
| |- | | |- |
| | colspan="3" rowspan="18" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | rowspan="18" style="background: #DCDCDC; padding: 5px; text-align: left;" | |
| * Vesicular/Ulcerative/Erythematous | | * Vesicular/Ulcerative/Erythematous |
| |Hereditary | | | |
| |Epidermolysis bullosa | | * Hereditary |
| | | |
| | * Epidermolysis bullosa |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" | | | | style="background: #F5F5F5; padding: 5px;" | |
Line 768: |
Line 812: |
| | style="background: #F5F5F5; padding: 5px;" | | | | style="background: #F5F5F5; padding: 5px;" | |
| |- | | |- |
| | rowspan="6" |Viral | | | rowspan="6" | |
| |Herpes simplex | | * Viral |
| | | |
| | * Herpes simplex |
| | | | | |
| | | | | |
Line 777: |
Line 823: |
| | | | | |
| |- | | |- |
| |Herpangina | | | |
| | * Herpangina |
| | | | | |
| | | | | |
Line 785: |
Line 832: |
| | | | | |
| |- | | |- |
| |Hand foot and mouth disease | | | |
| | * Hand foot and mouth disease |
| | | | | |
| | | | | |
Line 793: |
Line 841: |
| | | | | |
| |- | | |- |
| |Herpes zoster | | | |
| | * Herpes zoster |
| | | | | |
| | | | | |
Line 801: |
Line 850: |
| | | | | |
| |- | | |- |
| |Infectious mononucleosis | | | |
| | * Infectious mononucleosis |
| | | | | |
| | | | | |
Line 809: |
Line 859: |
| | | | | |
| |- | | |- |
| |Varicella | | | |
| | * Varicella |
| | | | | |
| | | | | |
Line 817: |
Line 868: |
| | | | | |
| |- | | |- |
| | rowspan="5" |Autoimmune | | | rowspan="5" | |
| |Erosive lichen planus | | * Autoimmune |
| | | |
| | * Erosive lichen planus |
| | | | | |
| | | | | |
Line 826: |
Line 879: |
| | | | | |
| |- | | |- |
| |Mucous memrane pemphigoid | | | |
| | * Mucous memrane pemphigoid |
| | | | | |
| | | | | |
Line 834: |
Line 888: |
| | | | | |
| |- | | |- |
| |Pemphigous vulgaris | | | |
| | * Pemphigous vulgaris |
| | | | | |
| | | | | |
Line 842: |
Line 897: |
| | | | | |
| |- | | |- |
| |Bullous pemphigoid | | | |
| | * Bullous pemphigoid |
| | | | | |
| | | | | |
Line 850: |
Line 906: |
| | | | | |
| |- | | |- |
| |Lupus erythmatosus | | | |
| | * Lupus erythmatosus |
| | | | | |
| | | | | |
Line 858: |
Line 915: |
| | | | | |
| |- | | |- |
| | rowspan="5" |Idiopathic | | | rowspan="5" | |
| |Aphthous ulcer | | * Idiopathic |
| | | |
| | * Aphthous ulcer |
| | | | | |
| | | | | |
Line 867: |
Line 926: |
| | | | | |
| |- | | |- |
| |Erythema multiforme | | | |
| | * Erythema multiforme |
| | | | | |
| | | | | |
Line 875: |
Line 935: |
| | | | | |
| |- | | |- |
| |Erythroplakia | | | |
| | * Erythroplakia |
| | | | | |
| | | | | |
Line 883: |
Line 944: |
| | | | | |
| |- | | |- |
| |Medication induced mucositis | | | |
| | * Medication induced mucositis |
| | | | | |
| | | | | |
Line 891: |
Line 953: |
| | | | | |
| |- | | |- |
| |Contact stomatitis | | | |
| | * Contact stomatitis |
| | | | | |
| | | | | |
Line 899: |
Line 962: |
| | | | | |
| |- | | |- |
| |Mycotic | | | |
| |Candidiosis | | * Mycotic |
| | | |
| | * Candidiosis |
| | | | | |
| | | | | |
Line 908: |
Line 973: |
| | | | | |
| |- | | |- |
| ! colspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign Oral lesions | | ! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Soft Tissue Lesion |
| !
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features |
Line 916: |
Line 980: |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | rowspan="38" style="background: #DCDCDC; padding: 5px; text-align: left;" | |
| * Pyogenic granuloma | | * Tumor/Neoplasms |
| | | | | rowspan="24" |Benign |
| | | | | rowspan="3" |Epithelial |
| | | | | |
| | * Papilloma |
| | style="background: #F5F5F5; padding: 5px;" | | | | style="background: #F5F5F5; padding: 5px;" | |
| | style="background: #F5F5F5; padding: 5px;" | | | | style="background: #F5F5F5; padding: 5px;" | |
Line 927: |
Line 992: |
| | style="background: #F5F5F5; padding: 5px;" | | | | style="background: #F5F5F5; padding: 5px;" | |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | |
| * Peripheral ossifying fibroma
| | * Verruca vulgaris |
| | | |
| | | |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | |
| * Granular cell tumor
| | * Condyloma acuminatum |
| | | |
| | | |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | rowspan="14" |Mesenchymal |
| * Peripheral giant cell granuloma | | | |
| | * Fibroma |
| | | |
| | | |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | |
| * Oral hemangioma
| | * Peripheral ossifying fibroma |
| | | |
| | | |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Benign peripheral nerve sheath tumor
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Traumatic neuroma
| |
| | | | | |
| | * Leiomyoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Neurofibroma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Schwannoma
| |
| | | | | |
| | * Rhabdomyoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Palisaded encapsulated neuroma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | | | | |
| | * Peripheral giant cell granuloma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Neodymium-doped yttrium alluminium garnet
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | rowspan="11" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Pigmented lesions
| |
| | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Diffuse
| |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Peutz-jeghers syndrome
| |
| | | | | |
| | * Hemangioma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Addison's disease
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Heavy metal
| |
| | | | | |
| | * Lymphangioma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Drug induced
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Post inflammatory
| |
| | | | | |
| | * Pyogenic granuloma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Smoker's melanosis
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Focal
| |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Ephelides
| |
| | | | | |
| | * Lipoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Labial melanocytic macules
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Amalgam tattoo
| |
| | | | | |
| | * Neuroma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Oral melanoacanthoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Oral melanocytic nevi
| |
| | | | | |
| | * Neurofibroma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pre-malignant oral lesions
| |
| !
| |
| !
| |
| !
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnostic procedure
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Treatment
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Leukoplakia
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Oral proliferative verrucous leukoplakia
| |
| | | | | |
| | * Schwannoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Erythroplakia
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Oral submucus fibrosis
| |
| | | | | |
| | * Granular cell tumor |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Oral lichen planus and lichenoid lesions
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Oral discoid lupus erythmatosus
| |
| | | | | |
| | * Congenital epulis |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Oral chronic graft vs host disease
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | rowspan="7" |Salivary gland |
| * Actinic chelitis
| |
| | | | | |
| | * Pleomorphic adenoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignant oral lesions
| |
| !
| |
| !
| |
| !
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnostic procedure
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Treatment
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
| |
| |-
| |
| | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Epithelial tissue origin
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Squamous cell carcinoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Basal cell carcinoma
| |
| | | | | |
| | * Papillary cystadenoma lymphomatosum |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Verrucous crcinoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Spindle cell carcinoma
| |
| | | | | |
| | * Adenoid cystic carcinoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Adenoid squamous cell carcinoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Lymphoepithelioma and transitional cell carcinoma
| |
| | | | | |
| | * Acinic cell adenocarcinoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Malignant melanoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Nerve tissue origin
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Malignant schwannoma
| |
| | | | | |
| | * Mucoepidermoid carcinoma low grade |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Muscle tissue origin
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Leiomyosarcoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Rhabdomyosarcoma
| |
| | | | | |
| | * Polymorphous low grade adenocarcinoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | rowspan="7" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Lymphoid tissue origin
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Malignant lymphoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Non Hodgkin lymphoma
| |
| | | | | |
| | * Acinic cell adenocarcinoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Hodgkin lymphoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | rowspan="4" |Cyst |
| *Burkitt's lymphoma | | | |
| | * Gingival cyst of adult |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Reticular cell sarcoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Plasma cell tumor | | * Lymphoepithelial cyst |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Multiple myeloma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Plasmacytoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Connective and Adipose tissue origin | | * Epidermoid/dermoid cyst |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Fibrosarcoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Liposarcoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Tumors of disputed origin | | * Thyroglossal tract cyst |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Granular cell myoblastoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Congenital epulis
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | rowspan="10" |Malignant |
| * Alveolar soft part sarcoma | | | |
| | * Squamous cell carcinoma |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Melanocytic neuroectodermal tumor of infancy
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Kaposi sarcoma | | * Verrucous carcinoma |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Ewing's sarcoma
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infections
| | | |
| !
| | * Lymphoma |
| !
| |
| !
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnostic procedure
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Treatment
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Herpes simplex virus | |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Varicella zoster virus
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Coxsackie virus | | * Melanoma |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * HIV infection
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Syphilis | | * Sarcoma |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Other infections
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Autoimmune Conditions
| | | rowspan="4" | |
| !
| | * Salivary gland adenocarcinoma |
| !
| |
| !
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnostic procedure
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Treatment
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Oral erosive lichen planus | |
| | | | | |
| | * Adenoid cystic carcinoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Systemic lupus erythamtosus
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Mucus membrane pemphigoid
| |
| | | | | |
| | * Mucoepidermoid carcinoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Bullous pemphigoid
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Pemphigus vulgaris
| |
| | | | | |
| | * Polymorphous low grade adenocarcinoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Paraneoplastic pemphigus
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Epidermolysis bullosa acquisita
| |
| | | | | |
| | * Acinic cell adenocarcinoma |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Miscellaneous
| |
| !
| |
| !
| |
| !
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnostic procedure
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Treatment
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Burning mouth syndrome
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Contact stomatitis | | * Metastatic carcinoma |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Cheilitis
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | | rowspan="6" style="background: #DCDCDC; padding: 5px; text-align: left;" | |
| * Mucoceles | | * Reactive |
| | | | | |
| | * Sinus track |
| | | | | |
| | | | | |
Line 1,778: |
Line 1,316: |
| | style="background: #F5F5F5; padding: 5px;" | | | | style="background: #F5F5F5; padding: 5px;" | |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Torus | | * Periodontal abscess |
| | | |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Dental erosions/Gingival overgrowth
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Telangiectasias | | * Mucocele |
| | | |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: left;" |Tongue lesions
| |
| !
| |
| !
| |
| !
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diagnostic procedure
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Treatment
| |
| ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Atrophic glossitis
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Fissured tongue | | * Fibrous hyperplasia |
| | | |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Black tongue
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Black hairy tongue | | * Inflammatory papillary hyperplasia |
| | | |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Pigmented fungiform papillae of the tongue
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |- | | |- |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| | | |
| * Geographic tongue | | * Necrotizing sialometaplasia |
| | | |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |-
| |
| | colspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" |
| |
| * Median rhomboid glossitis
| |
| | | | | |
| | | | | |
| | | | | |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| | style="background: #F5F5F5; padding: 5px;" |
| |
| |} | | |} |
| {| class="wikitable" | | {| class="wikitable" |